(5) Growth factor and receptor signaling pathways: IGF1R, IGFBP6, IGFL2, EGFR, PDGFA, and VEGFA. Previous studies have demonstrated that abnormal activation of these pathways promotes epithelial-derived tumor expansion and progression through promotion of EMT-like transitions. This evidence concerns the gene IGFL2 and neoplasm.